921P Pembrolizumab plus docetaxel for the treatment of recurrent metastatic head and neck cancer: A prospective phase I/II study
| Autor: | Fuereder, T., Minichsdorfer, C., Mittlboeck, M., Wagner, C., Oberndorfer, F., Müllauer, L., Aretin, M-B., Czerny, C., Schwarz-Nemec, U. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S665-S665 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|